| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |